Regarding clinicpathological parameters, the increased expression of MISP or PLK1 was significantly correlated with tumor number, N stage, and lymphatic invasion (Table 1), indicating that its impact on iCCA progression and high expression of PLK1 and MISP could be used to predict the survival of iCCA patients. This evidence concerns the gene PLK1 and neoplasm.